Leave Your Message
*Name Cannot be empty!
* Enter product details such as size, color,materials etc. and other specific requirements to receive an accurate quote. Cannot be empty
News

Vitamin K1 (Phylloquinone): The Guardian of Life's Coagulation

2026-04-08

Vitamin K1, also known as Phylloquinone or Phytomenadione, is a fat-soluble vitamin and a core member of the vitamin K family. It naturally exists in green leafy vegetables (such as spinach, kale, and broccoli) and is an indispensable nutrient for human blood coagulation and bone health.

Core Characteristics

 Essential for Coagulation: Essential coenzyme for liver synthesis of coagulation factors II, VII, IX, and X, maintaining normal coagulation function

 Fat-Soluble: Requires fat for absorption, better efficacy when taken with dietary fats

 Natural Source: Synthesized by green plants through photosynthesis, chemical structure is 2-methyl-3-phytyl-1,4-naphthoquinone

 Dual Identity: Both a clinical emergency drug and a daily nutritional supplement

Commercially available Vitamin K1 is mainly produced through chemical synthesis or extraction from natural plants, widely used in pharmaceuticals, food fortification, feed additives, and dietary supplements.

Core Benefits: Why Vitamin K1 Is Indispensable

Vitamin K1 1.jpg

  • Blood Coagulation and Hemostasis

The most core function of Vitamin K1 is participating in the coagulation mechanism:

 Activates Coagulation Factors: As a cofactor for γ-glutamyl carboxylase, converts inactive coagulation factor precursors into active forms.

 Promotes Prothrombin Synthesis: Essential substance for liver synthesis of prothrombin (factor II).

 Clinical Hemostasis: Treats bleeding disorders caused by Vitamin K deficiency, such as obstructive jaundice, biliary fistula, and bleeding due to chronic diarrhea.

 Anticoagulation Reversal: Reverses bleeding caused by excessive anticoagulants such as warfarin.

Hemorrhagic disease of the newborn (VKDB) is a serious consequence of Vitamin K1 deficiency, with 35 cases per 100,000 newborns, making routine Vitamin K1 injection after birth a standard prevention measure.

  • Bone Health and Calcium Metabolism

Vitamin K1 plays an important role in bone health:

 Osteocalcin Activation: Activates osteocalcin, promoting calcium ion deposition in bones.

 Inhibits Calcium Loss: Reduces urinary calcium excretion, maintains calcium balance.

 Fracture Prevention: Adequate Vitamin K1 intake is associated with increased bone density and reduced fracture risk.

  • Cardiovascular Protection

 Inhibits Vascular Calcification: Through activation of matrix Gla protein (MGP), prevents calcium deposition in arterial walls

 Maintains Vascular Elasticity: Reduces arteriosclerosis risk

 Anti-inflammatory Effects: Reduces vascular inflammatory responses

  • Antispasmodic and Analgesic Effects

Vitamin K1 has smooth muscle antispasmodic effects:

 Visceral Colic: Relieves biliary colic, intestinal colic, and ureteral colic

 Bronchospasm: Has certain bronchodilatory effects

 Muscle Spasm: Reduces pain caused by smooth muscle spasms

  • Liver Protection

High-dose Vitamin K1 shows liver protection potential:

 Promotes Hepatocyte Survival: Enhances liver cell vitality

 Enhances Phagocytic Function: Activates the mononuclear phagocyte system

 Chronic Hepatitis Support: Has certain auxiliary therapeutic effects on chronic hepatitis

Major Application Fields

Vitamin K1 2.jpg

  • Pharmaceutical Preparations (Core Market)

The primary application of Vitamin K1 is clinical medicine:

 Neonatal Care: Standard protocol for preventing hemorrhagic disease of the newborn.

 Anticoagulation Management: Warfarin excess or bleeding control during anticoagulant therapy.

 Bleeding Disorders: Vitamin K deficiency bleeding, hypoprothrombinemia.

 Preoperative and Postoperative: Coagulation function maintenance before and after hepatobiliary and intestinal surgeries.

 Emergency Medicine: Emergency treatment of acute bleeding.

Dosage forms include injections (intravenous/intramuscular), oral tablets, and oral solutions. Injectable Vitamin K1 is an essential drug in hospital emergency departments and neonatal units.

  • Dietary Supplements

 Bone Health Formulas: Complex supplements synergistic with calcium and Vitamin D

 Cardiovascular Support: Vascular health products targeting middle-aged and elderly populations

 Multivitamins: Basic ingredient in multiple vitamin-mineral formulas

 Specific Populations: Patients with hepatobiliary diseases, chronic diarrhea, or long-term antibiotic users

  • Functional Foods and Beverages

 Infant Foods: Nutritional fortification of formula milk and rice cereal

 Plant Milk Alternatives: Synergistic fortification of calcium and Vitamin K in soy milk and oat milk

 Functional Beverages: Ready-to-drink nutritional supplements

 Breakfast Cereals: Fortified cereals and energy bars

  • Animal Nutrition and Feed

 Poultry Feed: Promotes skeletal development, prevents bleeding disorders

 Livestock Feed: Ensures liver health and coagulation function

 Pet Foods: Premium pet nutrition formulas

  • Cosmetics and Personal Care (Emerging Application)

 Skin Repair: Promotes wound healing, reduces bruising

 Anti-aging: Antioxidant, maintains skin health

 Postoperative Care: Recovery support after cosmetic surgery

Market Trends and Global Outlook

  • Steady Market Growth

The global Vitamin K1 market is experiencing steady growth. The total global Vitamin K market reached $1.07 billion in 2025, with Vitamin K1 occupying a dominant 68.4% share, expected annual growth rate of 8.3%. The Vitamin K1 injection segment was approximately $800 million in 2025, expected to reach $1.2 billion by 2035. Growth Drivers as follows:

 Population Aging: Increased demand for coagulation function and bone health in elderly populations

 Neonatal Healthcare: Global popularization of preventive Vitamin K1 use in newborns

 Growing Anticoagulant Therapy: Increased atrial fibrillation and thrombosis patients, rising demand for anticoagulation management

 Rise of Preventive Medicine: Consumers' increasing attention to bone and cardiovascular health

  • Product Innovation and Trends

Delivery Technology Improvements:

 Liposome Encapsulation: Improves stability and bioavailability of fat-soluble vitamins

 Nanoparticle Systems: Enhances absorption efficiency, reduces adverse reactions of injectables

 Sustained-release Formulations: Extends duration of action, reduces dosing frequency

Complex Formula Development:

 Vitamin K1 + Vitamin D + Calcium: Golden combination for bone health

 Vitamin K1 + Vitamin K2 (MK-7): Full-spectrum Vitamin K solution

 Multiple Vitamins and Minerals: Comprehensive nutritional support

FAQS

Q1: What is the difference between Vitamin K1 and Vitamin K2? Which should I choose?

A: Both are members of the vitamin K family, but with different functional focuses:

 Vitamin K1 (Phylloquinone): Mainly from green leafy vegetables, core function is coagulation, preferred for clinical hemostasis and neonatal preventive use.

 Vitamin K2 (Menaquinone): Mainly from fermented foods and gut bacteria, core function is bone and cardiovascular health (activating osteocalcin and matrix Gla protein).

 Selection Recommendation: Choose K1 for hemostasis or anticoagulation management; choose K2 (especially MK-7 form) for bone health focus. Some premium formulas combine K1 + K2 for full-spectrum coverage.

Q2: Why do newborns need Vitamin K1 injection? Is there risk without it?

A: Newborns have not yet established intestinal flora and cannot synthesize vitamin K, plus breast milk has low K1 content, making them highly susceptible to deficiency. Deficiency can lead to Vitamin K Deficiency Bleeding (VKDB), manifesting as skin bruising, gastrointestinal bleeding, or even intracranial hemorrhage, with high mortality. A 1mg Vitamin K1 injection is the standard protocol for preventing VKDB, safe and effective, universally recommended globally.

Q3: Can Vitamin K1 overdose be toxic?

A: Vitamin K1 has high safety, with natural forms having almost no toxicity. However, synthetic Vitamin K3 (menadione) has potential toxicity and has been restricted. High-dose K1 (far exceeding recommended amounts) may cause hemolytic anemia or hyperbilirubinemia (especially in G6PD-deficient individuals), but conventional doses (90-120μg/day for adults) are very safe.

Q4: Is Vitamin K1 stable in formulations? How to protect activity?

A: Vitamin K1 presents significant stability challenges:

 Destabilizing Factors: Light, alkaline conditions, oxidizers

 Protection Measures: Light-protected packaging (brown bottles/aluminum foil bags), nitrogen flushing for oxygen isolation, acidic to neutral pH formulations, addition of antioxidants (such as Vitamin E).

 Dosage Form Recommendations: Soft capsules superior to tablets (better oxygen barrier), injectables require light-protected storage.

 

  • Name: Daisy Jia
  • Email: imaherb@aogubio.com
  • WhatsApp: +86-18149253521